Oncology Advances
Featured Content |Content Library
Three-Drug Combination Therapy Effective in Patients with High-Risk CLL, Trial Shows
A three-drug combination that sent chronic lymphocytic leukemia (CLL) into deep remissions in a broad group of patients in a clinical trial is highly effective in patients with high-risk forms of the disease, a new, phase 2 clinical trial ...
Dana-Farber Cancer Institute Faculty Among World’s Most Highly Cited Researchers
Dana-Farber Cancer Institute is proud to announce that 33 of its researchers have been named to the Highly Cited Researchers list of 2022 released today by the Institute for Scientific Information at Clarivate.
Dana-Farber Research Supports FDA Approval of New Therapy for Certain Patients with Ovarian Cancer
A novel antibody drug conjugate therapy whose clinical trial testing has been co-led by Ursula Matulonis, MD, of the Dana-Farber Cancer Institute has been granted accelerated approval by the U.S. Food and Drug Administration (FDA) on November ...
50 Years of Innovation, Progress, and Exceptional Care in Stem Cell Transplantation
Fifty years ago, Brigham and Women's Hospital and Boston Children's Hospital initiated a joint bone marrow transplant program. In the early 1980s, Dana-Farber launched its own transplant program.
Dana-Farber physician-scientists will share research and clinical advances at the 2022 Annual Meeting of the American Society of Hematology (ASH) December 10-13.
Episode 1: The Wolf in Sheep's Clothing
The parable of the wolf in sheep’s clothing tale reminds us that things aren’t always as they seem, that bad guys can dress up as good guys to do their bad guy things.
Receive Dana-Farber's e-newsletter, Momentum, to learn of advances in cancer research and care, current clinical trials, and upcoming CME programs.
SPOTLIGHT
- American Society of Hematology (ASH) Annual Meeting
- San Antonio Breast Cancer Symposium
- Center for Protein Degradation - Royal Chemistry Society
- Breast Cancer Treatment
Guidelines - Research News Updates
- Faculty Updates
- Symposium Highlights 75 Years of Dana-Farber Science
CME
